¥ÍÂå°ê»Ú±ÂÅvª÷ÃB¼W3.6¿ ¥h¦~11¶µ²£«~³ø±¶ ±a°ÊÁ`³W¼Ò¬ð¯}490»õ¤¸ ¬R®i275»õ¤¸³Ì¦h
¥Íµ¦·|¬Q¡]1¡^¤é¤½¥¬2023¦~¥xÆW¥ÍÂå²£«~¬ãµo¡]ÃÄ«~¡BÂå§÷¡^°ê»Ú±ÂÅvÁ`³W¼Ò¡A¦@¦³11¶µ²£«~¦¨¥\±À¶i°ê»Ú±ÂÅv¡A¬Û¸û2022¦~¼W¥[¤¶µ¡A¥Ø«e¤w´¦ÅS±ÂÅvÁ`ª÷ÃB¹O15.36»õ¬ü¤¸¡]¬ù·s¥x¹ô490.86»õ¤¸¡^¡A¶W¹L2022¦~ªº3.3»õ¬ü¤¸¡A¦¨ªø3.65¿¡C
¥Íµ¦·|ªí¥Ü¡A2023¦~¬O¥xÆW¥ÍÂå²£«~¬ãµo°ê»Ú±ÂÅvÂצ¬ªº¤@¦~¡A±q¥h¦~3¤ë¦Ü10¤ë¦@§¹¦¨¤Q®a·sÃĶ}µo¥H¤Î¤@®aÂå§÷±ÂÅv®×¡C¥Íµ¦·|²Îp¡A5,000¸U¬ü¤¸¥H¤Wªº·sÃıÂÅv®×¦@¦³¤¥ó¡A¨ä¤¤¬R®i·sÃıÂÅvÁ`ª÷ÃB8.62»õ¬ü¤¸¡]¬ù·s¥x¹ô275.6»õ¤¸¡^³W¼Ò³Ì°ª¡C
³o¤¥ó·sÃĶ}µo¤j«¬±ÂÅv®×¤¤¡A¦@¦³¤T¥óÄÝ©ó505¡]b¡^¡]2¡^·sÃÄ¡A¥t¥~¤j¤À¤l¤Î¤p¤À¤l·sÃıÂÅv¦U¦³¤@¥ó¡A¤À§O¬°¬R®i·sÃĪº505¡]b¡^¡]2¡^·sÃÄALA-1000ªº8.62»õ¬ü¤¸¡B¦w°ò¥Í§Þ¤p¤À¤l·sÃÄAJ201ªº2.5»õ¬ü¤¸¡B°ê¨¶ÃÄ«~505¡]b¡^¡]2¡^·sÃÄL606ªº2.25»õ¬ü¤¸¡BÃĵØÂåÃĤj¤À¤l·sÃĦʴµ·ç©ú¡]1.1»õ¬ü¤¸¡^¡A¥H¤Î¥x·sÃÄ505¡]b¡^¡]2¡^ ·sÃÄAPP13007ªº8,600¸U¬ü¤¸¡C
¦¹¥~¡A³o¤¶µ§¹¦¨°ê»Ú±ÂÅvªº®×¨Ò¤¤¡AÃĵØÃĪvÀø¯u©Ê¬õ¦å²y¼W¦h¯g¡]PV¡^ªº·sÃĦʴµ·ç©ú¤w¦b¬ü°ê¡B¤é¥»µ¥°ê¤W¥«¡A«á¨Ó¦A»P°ê»ÚÃļtPint-Pharma GmbHñ¸p©Ô¤B¬ü¬w¤C°ê°Ó·~±ÂÅv¦X¬ù¡AÁ`ª÷ÃB³Ì°ª¥i¹F1.1»õ¬ü¤¸¡A¥H¤Î¤W¥««áÂù¦ì¼Æ¦Ê¤À¤ñªº¾P°âÅv§Qª÷¡C
¥x·sÃÄ2023¦~8¤ë»P¬ü°ê¤W¥«»sÃĤ½¥qEyenovia, Inc.ñ¸p¬ü°ê¥«³õ¿W®a±ÂÅv¦X¬ù¡C¥x·sÃÄÀò±oñ¬ùª÷¡Bµo®i¨½µ{ª÷¤Î¾P°â¨½µ{ª÷¦Xp³Ì°ª8,600¸U¬ü¤¸¡C³o¶µÃĪ«¤wÀò¬ü°êFDA³qª¾¡A¹wp2024¦~¤¤®i¶}¾P°â¡C
Âå§÷±ÂÅv¤è±¡A³ÕÑÔ¥ÍÂåºX¤U¬ãµo¤¤°©¦A¥Í²£«~°©¥Íªø¦]¤l¡]OIF¡^¥h¦~4¤ë»P¤é¥»ÃÃ¥»»sÃĮ覡·|ªÀñ¸p¤é¥»¿W®a±ÂÅv¦X¬ù¡A±N¥ÑÃÃ¥»»sÃÄt³d¦b¤é¥»°õ¦æªº«áÄòÁ{§É¸ÕÅç¤Î¨úÃÒ¤W¥«ªº¥þÃB¶O¥Î¡C <ºK¿ý¸gÀÙ>